Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $28.87 ($360,821)
  10. 4 Open-market sale President and CEO sold 4,000 shares at an average $33.03 ($132,102)
  11. 4 Option exercise Chief Business Officer acquired 4,500 shares (option exercise)
  12. 4 Open-market sale President and CEO sold 3,500 shares at an average $28.64 ($100,224)
  13. 4 Open-market sale President and CEO sold 3,500 shares at $30.33 ($106,161)
  14. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $39.41 ($492,678)
  15. 4 Open-market sale President and CEO sold 3,500 shares at an average $38.52 ($134,835)
  16. 4 Option exercise Chief Financial Officer acquired 20,000 shares (option exercise)
  17. 4 Open-market sale President and CEO sold 3,500 shares at an average $32.67 ($114,352)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 215 filings